» Articles » PMID: 31918310

Genetic Susceptibility May Modify the Association Between Cell Phone Use and Thyroid Cancer: A Population-based Case-control Study in Connecticut

Overview
Journal Environ Res
Publisher Elsevier
Date 2020 Jan 10
PMID 31918310
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Emerging studies have provided evidence on the carcinogenicity of radiofrequency radiation (RFR) from cell phones. This study aims to test the genetic susceptibility on the association between cell phone use and thyroid cancer. Population-based case-control study was conducted in Connecticut between 2010 and 2011 including 440 thyroid cancer cases and 465 population-based controls with genotyping information for 823 single nucleotide polymorphisms (SNPs) in 176 DNA genes. We used multivariate unconditional logistic regression models to estimate the genotype-environment interaction between each SNP and cell phone use and to estimate the association with cell phone use in populations according to SNP variants. Ten SNPs had P < 0.01 for interaction in all thyroid cancers. In the common homozygote groups, no association with cell phone use was observed. In the variant group (heterozygotes and rare homozygotes), cell phone use was associated with an increased risk for rs11070256 (odds ratio (OR): 2.36, 95% confidence interval (CI): 1.30-4.30), rs1695147 (OR: 2.52, 95% CI: 1.30-4.90), rs6732673 (OR: 1.59, 95% CI: 1.01-2.49), rs396746 (OR: 2.53, 95% CI: 1.13-5.65), rs12204529 (OR: 2.62, 95% CI: 1.33-5.17), and rs3800537 (OR: 2.64, 95% CI: 1.30-5.36) with thyroid cancers. In small tumors, increased risk was observed for 5 SNPs (rs1063639, rs1695147, rs11070256, rs12204529 and rs3800537), In large tumors, increased risk was observed for 3 SNPs (rs11070256, rs1695147, and rs396746). Our result suggests that genetic susceptibilities modify the associations between cell phone use and risk of thyroid cancer. The findings provide more evidence for RFR carcinogenic group classification.

Citing Articles

Nanofiber-based delivery of evodiamine impedes malignant properties of intrahepatic cholangiocarcinoma cells by targeting HDAC4 and restoring TPM1 transcription.

Zou R, Wang Y, Cai Y, Xing Z, Shao Y, Li D Hum Cell. 2024; 37(5):1505-1521.

PMID: 39073525 DOI: 10.1007/s13577-024-01105-7.


Ulnar Nerve Entrapment Among Cell Phone Users: Cell Phone Elbow (Cubital Tunnel Syndrome).

Ukkirapandian K, Vp S, Pawar A, Udaykumar K, Rangasmy M Cureus. 2024; 16(3):e55500.

PMID: 38571821 PMC: 10990069. DOI: 10.7759/cureus.55500.


Letter to Editor on "Impact of smart phone use on adolescence health in India".

Chakraborty B, De R Bioinformation. 2024; 20(1):36-38.

PMID: 38352905 PMC: 10859940. DOI: 10.6026/973206300200036.


Exploring temporal trends and influencing factors for thyroid cancer in Guangzhou, China: 2004-2018.

Zhou J, Liang B, Liu Y, Wang S, Xu H, Li K Endocrine. 2023; 84(2):509-523.

PMID: 37936008 DOI: 10.1007/s12020-023-03578-2.


Interaction between Genetic Risks and Socioeconomic Factors on Thyroid Cancer: Evidence from 0.5 Million UK Biobank Participants.

Li Y, Zhan Y, Mao W, Wang B, Dong P, Na R Cancers (Basel). 2023; 15(20).

PMID: 37894396 PMC: 10605197. DOI: 10.3390/cancers15205028.


References
1.
Frei P, Poulsen A, Johansen C, Olsen J, Steding-Jessen M, Schuz J . Use of mobile phones and risk of brain tumours: update of Danish cohort study. BMJ. 2011; 343:d6387. PMC: 3197791. DOI: 10.1136/bmj.d6387. View

2.
Boyd S, Tsai K, Jacks T . An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nat Cell Biol. 2000; 2(9):563-8. DOI: 10.1038/35023500. View

3.
Miller A, Morgan L, Udasin I, Davis D . Cancer epidemiology update, following the 2011 IARC evaluation of radiofrequency electromagnetic fields (Monograph 102). Environ Res. 2018; 167:673-683. DOI: 10.1016/j.envres.2018.06.043. View

4.
Oliner J, Pietenpol J, Thiagalingam S, Gyuris J, Kinzler K, Vogelstein B . Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature. 1993; 362(6423):857-60. DOI: 10.1038/362857a0. View

5.
Liu T, Li Y, Gu H, Zhu G, Li J, Cao L . p21-Activated kinase 6 (PAK6) inhibits prostate cancer growth via phosphorylation of androgen receptor and tumorigenic E3 ligase murine double minute-2 (Mdm2). J Biol Chem. 2012; 288(5):3359-69. PMC: 3561555. DOI: 10.1074/jbc.M112.384289. View